All entries by this author

J&J Federal Trial – Transvaginal Tape Risks Outweigh Benefits

Aug 27th, 2014 | By
J&J Federal Trial – Transvaginal Tape Risks Outweigh Benefits

Tuesday in the trial of Huskey v. Ethicon, the fourth jury trial over Johnson & Johnson’s controversial transvaginal meshes, Dr. Bruce Rosenzweig, an expert for the plaintiff, told jurors he had implanted 15 or 20 of the polypropylene slings. He stopped doing them after seeing patient complications and today only does the burch procedure using
[continue reading...]



Jury Reacts to Minimally Invasive Transvaginal Mesh Procedure

Aug 26th, 2014 | By
Jury Reacts to Minimally Invasive Transvaginal Mesh Procedure

Day Two- Morning Session ~ The second day of the Huskey v Ethicon trial commenced with Dr. Bruce Rosenzweig on the stand for a second day. Monday he was established as an expert in the case. The urogynecologist with Rush University Medical Center in Chicago is in private practice where he used to use TVT
[continue reading...]



Federal Mesh Trial Against J&J: Missing Documents

Aug 25th, 2014 | By
Federal Mesh Trial Against J&J: Missing Documents

DAY ONE CONTINUES ~Afternoon Session~ Information contained in a missing box of Johnson & Johnson (J&J) documents, thought to have been destroyed, led the afternoon session in this opening day of Huskey v. Ethicon, a defective product trial that puts Johnson & Johnson and its controversial transvaginal mesh products on the global spotlight. The case
[continue reading...]



Federal Mesh Trial Against J&J Opens in West Virginia

Aug 25th, 2014 | By
Federal Mesh Trial Against J&J Opens in West Virginia

Jo Huskey was in a Charleston, West Virginia courtroom today where her legal team will try to prove to a jury of seven that the transvaginal mesh she was implanted with in February 2011 was defective. Monday were opening arguments for her legal team as well as lawyers representing Ethicon and its parent company Johnson
[continue reading...]



Huskey v Ethicon Case Opens Monday

Aug 24th, 2014 | By
Huskey v Ethicon Case Opens Monday

The product liability case that could turn the tide for healthcare giant Johnson & Johnson over its controversial transvaginal mesh implants begins Monday, August 25.  Jo Huskey, 54, was implanted with a TVT-O, a vaginal sling made of polypropylene (PP) mesh, on February 23, 2011 to treat stress urinary incontinence (SUI). She experienced mesh erosion
[continue reading...]



Cardenas V. Boston Scientific Trial Continues

Aug 24th, 2014 | By
Cardenas V. Boston Scientific Trial Continues

Courtroom View Network is covering the Massachusetts product liability trial of Maria Cardenas v. Boston Scientific Corp. which ended its first week with the plaintiff resting. See CVN here. The trial began Thursday, August 14th with jury selection. Maria Cardenas vs. Boston Scientific Corp. (12-02912) is being heard in Superior Court of the Commonwealth of
[continue reading...]



A “Gold Standard” for Hernia Repair and the Patients’ Post-surgical Understanding of Unreasonable Mesh Device and Procedural Risks?

Aug 19th, 2014 | By
A “Gold Standard” for Hernia Repair and the Patients’ Post-surgical  Understanding of Unreasonable Mesh Device and Procedural Risks?

By David Schmidt Thank you Jane for this opportunity to share my experience as a U.S. hernia patient harmed, via the standard of care, by two large 4.3” x 6.3,” heavyweight, polypropylene Bard 3DMax Mesh implants. My story begins, as any patient’s does, with the blind trust placed in a physician. On April 18, 2007,
[continue reading...]



Huskey v. Ethicon Begins Friday

Aug 19th, 2014 | By
Huskey v. Ethicon Begins Friday

Jo Huskey (JH), 54, was implanted with a TVT-O, a vaginal sling made of Prolene mesh, on February 23, 2011. She experienced mesh erosion and dyspareunia (painful sex). As a result of her pelvic mesh complications, she had a revision surgery November 18, 2011. Only part of the medical device could be removed so her
[continue reading...]



POWER MORCELLATION and the Risk of Uterine Sarcoma Dissemination

Aug 15th, 2014 | By
POWER MORCELLATION and the Risk of Uterine Sarcoma Dissemination

By Dan Bolton, Keller, Fishback & Jackson LLP., Sponsored Content An estimated 50,000 women a year in the United States undergo a hysterectomy (removal of the uterus) or myomectomy (removal of uterine fibroids) with the use of a medical device known as a power morcellator. Power morcellators typically use a rapidly rotating blade to cut
[continue reading...]



Estelle Finds Complete TVT Removal

Aug 12th, 2014 | By
Estelle Finds Complete TVT Removal

“Estelle Tasz, 38, sat on the plane heading to St. Louis for her second pelvic mesh removal in as many months. She had surgery one month earlier at the University of California Los Angeles (UCLA) for removal of her transvaginal mesh, a TVT retropubic sling made by Ethicon (Johnson & Johnson). However, one hour after
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.